Presentation Information
[S05-07]Leishmania vaccine: Upcoming clinical trials, key challenges to overcome, and global partnerships
○Kawsar Talaat1 (1. Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health (United States of America))
Password required to view
Comment
To browse or post comments, you must log in.Log in